現代社会における社会福祉の一つの動向 : とくにコミュニティ・デベロップメントとの関連において ( 現代社会と社会福祉の課題)

Abstract

Nicorandil can significantly improve no-reflow phenomenon and major adverse cardiac events in patients undergoing primary percutaneous coronary intervention. The beneficial effects on major adverse cardiac events might be driven by the improvements of heart failure and ventricular arrhythmia. A combination of intracoronary and intravenous administration might be an optimal usage of nicorandil.